OTCMKTS:IZOZF Izotropic (IZOZF) Stock Price, News & Analysis → Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (From Weiss Ratings) (Ad) Free IZOZF Stock Alerts $0.08 -0.02 (-19.42%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$0.08▼$0.0850-Day Range$0.08▼$0.1152-Week Range$0.05▼$0.26Volume10,285 shsAverage Volume18,874 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Izotropic alerts: Email Address Ad Weiss RatingsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. About Izotropic Stock (OTCMKTS:IZOZF)Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.Read More IZOZF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IZOZF Stock News HeadlinesApril 18, 2024 | finance.yahoo.comIzotropic Corporation (1R3.F)January 30, 2024 | finance.yahoo.comIzotropic Receives Response From U.S. FDAJanuary 8, 2024 | finance.yahoo.comIzotropic Provides Regulatory and Operational UpdatesNovember 11, 2023 | morningstar.comIzotropic Corp IZONovember 9, 2023 | morningstar.comIzotropic Corp IZOZFNovember 1, 2023 | finanznachrichten.deIzotropic Corporation: Izotropic Completes Pre-Submission Meeting with U.S. FDANovember 1, 2023 | finance.yahoo.comIzotropic Completes Pre-Submission Meeting with U.S. FDASeptember 27, 2023 | finance.yahoo.comIzotropic Confirms FDA Pre-Submission Meeting DateSeptember 20, 2023 | finance.yahoo.comIzotropic Closes Non-Brokered Private PlacementSeptember 6, 2023 | finance.yahoo.comIzotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate DevicesJune 20, 2023 | finance.yahoo.comIzotropic Modifies Market Approval Pathway & StrategyJune 8, 2023 | finance.yahoo.comIzotropic CEO ResignsMarch 17, 2023 | ca.finance.yahoo.comIzotropic Corporation (IZOZF)February 23, 2023 | finance.yahoo.comIzotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT TechnologyFebruary 22, 2023 | finance.yahoo.comIzotropic Corporation (IZOZF) Stock Historical Prices & Data - Yahoo FinanceFebruary 19, 2023 | marketwatch.comIsotropic Graphite Market is Expected to Experience an Upward Trend in Terms of Growth and Expansion Forecast 2028January 9, 2023 | finance.yahoo.comIzotropic Releases First Video of IzoViewJanuary 5, 2023 | ca.finance.yahoo.comIzotropic Corporation (IZO.CN)January 4, 2023 | finance.yahoo.comIzotropic Reports Board Meeting ResultsDecember 1, 2022 | finanznachrichten.deIzotropic Corporation: Izotropic Completes IzoView Development and Assembly, Prepares for Final TestingDecember 1, 2022 | finance.yahoo.comIzotropic Completes IzoView Development and Assembly, Prepares for Final TestingNovember 11, 2022 | finanznachrichten.deIzotropic Corporation: Alexander Tokman Joins Izotropic Board of DirectorsNovember 11, 2022 | finance.yahoo.comAlexander Tokman Joins Izotropic Board of DirectorsOctober 25, 2022 | finance.yahoo.comIzotropic's IzoView Is Weeks Away from Final Engineering & Showcasing to Investment and Scientific CommunitiesAugust 11, 2022 | finance.yahoo.comIzotropic Finalizes Engineering and Development Transition to the United States; Establishes Operations in Primary Target MarketSee More Headlines Receive IZOZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Izotropic and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:IZOZF CUSIPN/A CIKN/A Webizocorp.com Phone833-496-2677FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Robert Louis Thast (Age 70)Founder, Interim CEO & Chairman Comp: $161.33kMr. Ralph F. Proceviat CPA (Age 74)Director & Interim CFO Dr. Younes Achkire Ph.D.Executive VP of Product Engineering & COOMr. Ali Reza SodagarLegal Advisor & Independent DirectorMs. Jaclyn ThastOperations Manager & Corporate SecretaryKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors IZOZF Stock Analysis - Frequently Asked Questions How have IZOZF shares performed in 2024? Izotropic's stock was trading at $0.0782 at the beginning of the year. Since then, IZOZF shares have increased by 6.1% and is now trading at $0.0830. View the best growth stocks for 2024 here. Are investors shorting Izotropic? Izotropic saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 7,300 shares, an increase of 192.0% from the April 30th total of 2,500 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 1.0 days. View Izotropic's Short Interest. How do I buy shares of Izotropic? Shares of IZOZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IZOZF) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Izotropic Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Izotropic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.